4World Health Organization. Global tuberculosis report 2012 [ R ] . Geneva: WHO, 2012.
5World Health Organization. Muhidrug and extensively drug-resistant TB (M/XDR- TB): 2010 global report on surveillance and response[ R]. Geneva: WHO, 2010.
6World Health Organization. Treatment of tuberculosis: guidelines [ R ] . Geneva: WHO, 2010.
7Almeida Da Silva PE, Palomino JC. Molecular basis and mechanisms of drug resistance in Mycobacterium tuberculosis: classical and new drugs[ J ]. J Antimicrob Chemother, 2011,66: 1417-1430.
8Blakemore R, Story E, Helb D, et al. Evaluation of the analytical performance of the Xpert MTB/RIF assay [ J ]. J Clin Microbiol, 2010, 48: 2495-2501.
9Boehme CC, Nabeta P, Hillemann D, et al. Rapid molecular detection of tuberculosis and rifampin resistance [ J ]. N Engl J Med, 2010, 363: 1005-1015.
10Maruri F, Sterling TR, Kaiga AW, et al. A systematic review of gyrase mutations associated with fluoroquinolone-resistant Mycobacterium tuberculosis and a proposed gyrase numbering system[J]. J Antimicrob Chemother, 2012, 67: 819-831.
